Position in PHAT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$387,681
+$186,957 QoQ
Shares Held
35,731
+97.8% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#89
of 161 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PHAT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Fiduciary Trust Co holds $29,735,828 across 28 Biotechnology names. PHAT ranks #14 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
19,400 | $9,636,561 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,318 | $5,186,605 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
17,991 | $3,369,353 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
8,416 | $2,028,002 | |
| 5 | VYGR |
Voyager Therapeutics, Inc.
|
334,397 | $1,170,389 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
2,471 | $781,057 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
8,537 | $635,835 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
7,399 | $586,666 |
All Filings in PHAT
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $387,681 | 35,731 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $200,724 | 18,067 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $266,103 | 16,040 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $189,673 | 16,115 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $104,578 | 10,905 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $68,374 | 10,905 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||